Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03818204 · ClinicalTrials.gov registry record · NA

Clinical Trial to Improve the Magnetic Levator Prosthesis

A NA study of Stroke and Traumatic Brain Injury, sponsored by Massachusetts Eye and Ear Infirmary.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03818204 is a NA study of Stroke and Traumatic Brain Injury that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 19 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03818204, a NA study of Stroke and Traumatic Brain Injury, has completed, sponsored by Massachusetts Eye and Ear Infirmary.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Blepharoptosis (incomplete opening of the eyelids) occurs because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. An external device could restore eyelid movement. A newer class of permanent magnets made of alloys of neodymium (Nd), iron (Fe) and boron (B) might provide the technology needed to develop a feasible external magnetic device that could restore eyelid movement.

Interventions

  • DEVICE Magnetic Levator Prosthesis (MLP)

Study Locations (1)

Massachusetts

  • Schepens Eye Research Institute - Boston

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2019-02-07
Est. Completion 2023-12-01
Phase NA

What the Registry Record Tells You About NCT03818204

The ClinicalTrials.gov registry entry for NCT03818204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Levator Prosthesis (MLP) is the first listed.

NCT03818204 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03818204 about?

NCT03818204 is a clinical study titled "Clinical Trial to Improve the Magnetic Levator Prosthesis". Blepharoptosis (incomplete opening of the eyelids) occurs because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. An external device could restore eyelid movement. A newer class of permanent magnets made of alloys of neodymium (Nd), iron (Fe) and boron (B) might prov...

What is the current status of trial NCT03818204?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-02-07. Estimated completion is 2023-12-01.

What conditions does trial NCT03818204 study?

This clinical trial studies the following conditions: Stroke, Traumatic Brain Injury, Myasthenia Gravis, Ptosis, Eyelid, Blepharoptosis.

What interventions are being tested in trial NCT03818204?

The interventions under investigation include: Magnetic Levator Prosthesis (MLP) (DEVICE).

Who is sponsoring clinical trial NCT03818204?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03818204 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.